Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J T Brouwer

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Liver|April 21, 1998
Hepatitis C virus genotypes: epidemiological and clinical associations. Benelux Study Group on Treatment of Chronic Hepatitis CB Kleter, J T Brouwer, F Nevens, et al.
Journal of Hepatology|July 22, 1998
Efficacy of interferon dose and prediction of response in chronic hepatitis C: Benelux study in 336 patientsJ T Brouwer, F Nevens, B Kleter, et al.
Gastroenterology|February 1, 1997
Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patientsG Fattovich, G Giustina, F Degos, et al.
Alimentary Pharmacology & Therapeutics|June 15, 2011
The role of mycophenolate mofetil in the management of autoimmune hepatitis and overlap syndromesA M C Baven-Pronk, M J Coenraad, H R van Buuren, et al.
The Netherlands Journal of Medicine|October 16, 2012
The 2012 revised Dutch national guidelines for the treatment of chronic hepatitis B virus infectionE H C J Buster, B C Baak, C M Bakker, et al.
The Netherlands Journal of Medicine|November 13, 2014
Dutch guidance for the treatment of chronic hepatitis C virus infection in a new therapeutic eraF A C Berden, W Kievit, L C Baak, et al.
The Netherlands Journal of Medicine|August 31, 2016
How the concept of biochemical response influenced the management of primary biliary cholangitis over timeW J Lammers, M Leeman, C I J Ponsioen, et al.
Genes and Immunity|January 23, 2015
HLA-DRB1*03:01 and HLA-DRB1*04:01 modify the presentation and outcome in autoimmune hepatitis type-1N M F van Gerven, Y S de Boer, A Zwiers, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Liver|April 21, 1998
Hepatitis C virus genotypes: epidemiological and clinical associations. Benelux Study Group on Treatment of Chronic Hepatitis CB Kleter, J T Brouwer, F Nevens, et al.
Journal of Hepatology|July 22, 1998
Efficacy of interferon dose and prediction of response in chronic hepatitis C: Benelux study in 336 patientsJ T Brouwer, F Nevens, B Kleter, et al.
Gastroenterology|February 1, 1997
Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patientsG Fattovich, G Giustina, F Degos, et al.
Alimentary Pharmacology & Therapeutics|June 15, 2011
The role of mycophenolate mofetil in the management of autoimmune hepatitis and overlap syndromesA M C Baven-Pronk, M J Coenraad, H R van Buuren, et al.
The Netherlands Journal of Medicine|October 16, 2012
The 2012 revised Dutch national guidelines for the treatment of chronic hepatitis B virus infectionE H C J Buster, B C Baak, C M Bakker, et al.
The Netherlands Journal of Medicine|November 13, 2014
Dutch guidance for the treatment of chronic hepatitis C virus infection in a new therapeutic eraF A C Berden, W Kievit, L C Baak, et al.
The Netherlands Journal of Medicine|August 31, 2016
How the concept of biochemical response influenced the management of primary biliary cholangitis over timeW J Lammers, M Leeman, C I J Ponsioen, et al.
Genes and Immunity|January 23, 2015
HLA-DRB1*03:01 and HLA-DRB1*04:01 modify the presentation and outcome in autoimmune hepatitis type-1N M F van Gerven, Y S de Boer, A Zwiers, et al.
Pageof 5